NovaBay Pharmaceuticals Depreciation & Amortization 2011-2026 | NBY

Annual Depreciation & Amortization NovaBay Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2002
-	40 K	51 K	120 K	59 K	51 K	65 K	266 K	95 K	114 K	164 K	232 K	314 K	341 K	425 K	427 K	373 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
427 K	40 K	196 K

Quarterly Depreciation & Amortization NovaBay Pharmaceuticals

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	1 K	1 K	2 K	-	1 K	8 K	12 K	-	13 K	13 K	13 K	-	29 K	29 K	30 K	-	13 K	11 K	9 K	-	12 K	14 K	14 K	-	17 K	16 K	17 K	-	92 K	86 K	41 K	-	18 K	18 K	18 K	-	31 K	27 K	40 K	-	41 K	82 K	41 K	-	185 K	141 K	70 K	-	240 K	161 K	2.65 M	-	256 K	174 K	91 K	-	321 K	216 K	107 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.65 M	1 K	121 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 34.45	4.74 %	$ 927 M	USA
Forte Biosciences FBRX	64 K	$ 20.31	1.2 %	$ 263 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 6.82	1.94 %	$ 187 M	Israel
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.62	-0.61 %	$ 431 M	Britain
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	475 K	$ 2.71	-0.92 %	$ 253 M	Israel
Anika Therapeutics ANIK	5.37 M	$ 15.14	2.16 %	$ 217 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	93.3 M	$ 97.08	1.55 %	$ 19 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.39	4.17 %	$ 5.58 M	Israel
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.51	2.03 %	$ 177 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 20.47	4.97 %	$ 2.6 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA